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Background: Recent evidence suggests that aberrant activation of Hedgehog (Hh) signaling by Gli transcription
factors is characteristic of a variety of aggressive human carcinomas including gastric cancer. Speckle-type POZ
protein, SPOP, is an E3 ubiquitin ligase adaptor, and it is found to inhibit oncogenic signaling. However, the
molecular mechanisms are largely unknown.
Methods: In this study, we characterized the expression of SPOP in 88 pairs of gastric cancer tissues and adjacent
tissues by immunohistochemical staining and Western blotting. The relationship between SPOP expression and
clinical pathologic factors was analyzed. Transfected gastric cancer cell lines were used in cell viability, wound
healing and colony formation assays. The interaction of SPOP with Gli2 and other related apoptotic proteins was
assessed by immunoprecipitation, Western blotting, real-time PCR and dual luciferase reporter assays. Intracellular
interaction of SPOP and Gli2 was visualized by immunofluorescent staining in gastric cancer cells.
Results: Immunohistochemical staining of SPOP can be detected in gastric cancer tissues but much less than
adjacent gastric tissues (P < 0.01). High SPOP expression is negatively correlated with lymph node metastasis, poor
histological differentiation, and tumor malignancy according to TNM staging. In vitro experiments revealed that
over-expression of SPOP prevented tumor cells from proliferation, migration and colony formation in gastric cancer
cell lines. Likewise, repression of SPOP promoted cell viability, migration, proliferation, and attenuated apoptosis.
Mechanistic studies revealed that increasing SPOP accelerated Gli2 degradation but regardless of Gli2 synthesis.
Furthermore, cytoplasmic Gli2 decreased markedly along with the abundant expression of SPOP in MKN45 cells.
Conclusions: Our findings indicate that SPOP plays critical roles in suppressing gastric tumorigenesis through
inhibiting Hh/Gli2 signaling pathway. It may provide an alternative strategy for developing therapeutic agents of
gastric cancer in future.
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Gastric carcinoma (GC), with an estimated number of one
million new cases every year, is the fourth most common
malignant tumor worldwide and the second most com-
mon cause of cancer-related deaths [1,2]. Although ex-
tensive research on the molecular mechanisms of GC
progression has been carried out, the prognosis of patients
with GC is still poor. Therefore, further understanding of* Correspondence: shiwenluo@ncu.edu.cn
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unless otherwise stated.the molecular mechanisms of GC progression and the de-
velopment of new therapeutic targets based on these
mechanisms are anticipated.
The Hedgehog (Hh) signaling pathway is crucial for the
growth and patterning of various tissues during embryonic
development [3]. Aberrant Hh pathway activation, driven
by either mutation or ligand overexpression, is often associ-
ated with human cancers [4,5]. This pathway is a highly co-
ordinated network of Hh (Sonic Hh, Indian Hh and Desert
Hh) proteins, seven-transmembrane protein Smoothened
(Smo), 12-transmembrane receptors (Patched1 [Ptch1] and
Patched2 [Ptch2]), and transcription factor Gli family (Gli1,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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a signaling cascade that culminates in an alteration of the
balance between activator and repressor forms of the Gli
transcription factors. The vertebrate Gli repressor func-
tion largely depends on Gli3, while the primary Gli activa-
tor function largely depends on Gli2. Gli1 acts as a
transcriptional activator and thus a reliable indicator of
Hh pathway activity [9,10]. In Drosophila, the Hh signal is
mediated by the Cubitus Interruptus (Ci) transcription
factor. Yet the Ci function is positively regulated by Fused
(Fu) serine/threonine kinase, but suppressed by Suppres-
sor of Fused (SuFu) and the kinesin-like molecule Costal2
(Cos2) [11]. SuFu is antagonized by HIB (Hh-induced
MATH and BTB domain protein), of which speckle-type
POZ protein, SPOP, is the vertebrate homolog [12].
SPOP is demonstrated as an E3 ubiquitin ligase adaptor.
It has 374 residues and contains three domains: an N-
terminal MATH domain (residues 28–166) that recruits
substrates, an internal BTB domain (residues 190–297)
that binds Cul3, and a C-terminal nuclear localization se-
quence (residues 365–374) [13]. SPOP is mostly studied
in ubiquitin-dependent proteolysis, however, its role in
tumorigenesis is largely unknown [13,14]. Li C., et al.
demonstrated that SPOP is responsible for full length Gli2
and Gli3 ubiquitination and proteolysis [15]. Recently,
Geng C., et al. revealed that wild type SPOP functions as a
critical tumor suppressor in prostate cancer cells by pro-
moting the turnover of SRC-3 (p160 steroid receptor
coactivator-3) protein and, thus suppressing androgen re-
ceptor transcription activity [16]. Wang C., et al. showed
that SPOP promotes full-length Gli2 and Gli3 degrad-
ation, which may indicate a potential tumor suppressor
role of SPOP [17]. The limited studies indicate the import-
ance of SPOP in tumorigenesis, which prompts us to find
out more evidence of it.
In this study, we evaluated SPOP expression in gastric
cancer tissues and adjacent gastric tissues. We then ex-
hibited possible correlations between SPOP expression
and the clinical pathologic factors. Based on the results
of clinical findings, we performed in vitro experiments
and studied the effects of up-regulated or down-regulated
SPOP expression on the proliferation, migration and
apoptosis of GC cell lines. Our results indicate that SPOP
reduces gastric cancer cell invasion and proliferation by
regulating Hh/Gli2 signaling pathway.
Methods
Constructs, antibodies and reagents
Human SPOP cDNA was amplified by PCR and then
inserted into KpnI and NotI sites of Pub6/V5-HisB vec-
tor. SPOP - miRNA (miR-SPOP) expressed vectors were
generated using the BLOCK-iT™ Pol II miR RNAi Expres-
sion Vector Kit (K4936-00, Invitrogen, Carlsbad, CA).
Clones were confirmed by DNA sequencing of bothstrands (Generay, Shanghai, China). The oligonucleotide
sequences for miRNA constructs were as follows: for miR-
SPOP-607, 5′-AAT GAC TTC ACC CAT TTC CTC-3′;
for miR-SPOP-917, 5′-TAA GCT TGT CAT CAG GGA
GAA-3′; and for miR-SPOP-1430, 5′-AGT TGA TGA
AAT CCA CTG CCT-3′. The numbers in the miRNA
constructs indicate the start of targeted nucleotide se-
quence of the gene. All transfectants were selected with
7 μg/ml Blasticidin for 3 weeks and selected clones were
identified by Western blotting. Antibodies were purchased
from Abcam (Gli2, ab26056; p16, ab108349; PTEN,
ab31392), Cell Signaling (Gli1, L42B10; Caspase-3, 9665S;
cleaved Caspase-3, 9664; Ki-67, 9449; Cyclin B1, 4135S;
p21, 2947; p27, 3686; Daxx, 4533; p-ERK, 4376S), Novus
(SPOP, H00008405-B01P), Protein-Tech (SPOP, 16750-1-
AP), Santa Cruz (PCNA, sc-9857; PARP, sc-7150; Actin, sc-
1616), Abgent (DUSP7, AP8450a), Millipore (GAPDH,
MAB374), Thermo (goat anti-rabbit IgG, 31460). Enhanced
chemiluminescence (ECL) Western blot detection re-
agents were from Thermo Fisher Scientific (Rockford, IL).
MG-132 (Z-Leu-Leu-Leu-CHO, I-130) was from Boston-
Biochem. Protease inhibitor cocktail, Lubrol-PX, and
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium brom-
ide (MTT) were purchased from Sigma-Aldrich (St. Louis,
MO).
Cell culture and tissue specimens
Human gastric epithelial cell line GES-1, human gastric
cancer cell lines AGS, MKN28, SGC-7901, MKN45 and
human embryonic kidney 293 T (HEK293T) cell lines
were obtained from American Type Culture Collection
(ATCC, Manassas). Cells were maintained in DMEM
(Invitrogen, CA) supplemented with 10% fetal bovine serum
(FBS; Invitrogen, CA) and 100 μg/ml streptomycin in hu-
midified incubator at 37°C with 5% CO2.
Gastric cancer samples were obtained from 88 patients
diagnosed gastric carcinoma from March 2007 to April
2010 in the Department of Pathology, the First Affiliated
Hospital of Nanchang University. All the patients had
not received chemotherapy or radiotherapy before sur-
gery and diagnosed by clinic pathologic staging based on
the 2010 American Joint Committee on Cancer (AJCC)
criteria. Detailed clinic pathologic information of all pa-
tients and their correlation with SPOP expression were
summarized in Table 1. This study was approved by the
institutional review board of the First Affiliated Hospital
of Nanchang University. All patients had given written
informed consent.
Immunohistochemical staining
Paraffin sections (5 μm) of formalin-fixed gastric cancer
tissue and adjacent tissue arrays were de-waxed, rehy-
drated and incubated in 3% H2O2 for 10 min to block en-
dogenous peroxidase. Then the sections were autoclaved
Table 1 Correlation between SPOP expression and clinic pathological information
Variable Groups SPOP expression scoring Spearman’s R P
Low (<6) High (≥6)
Gender Male 54 10
Female 22 2 −0.095 0.380
Age ≤50 18 1
>50 62 7 0.070 0.518
Lymp node Metastasis 54 4
No metastasis 23 7 0.236 0.027*
Histopathologic grading Poorly differentiated 34 0
Moderately differentiated 36 10
Well differentiated 8 0 −0.232 0.029*
TNM staging I 13 1
II 33 7
III + IV 30 4 −0.375 0.0003*
*Significant difference.
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mal goat serum (10%) was used to block non-specific
staining and then the tissue sections were exposed to indi-
cated antibodies. All of the stainings were observed by at
least 2 independent investigators blinded to the histopath-
ologic features and patient data of the samples [18]. The
widely accepted German semi-quantitative scoring system
was used for assessing the staining intensity and area ex-
tent [19]. Each specimen was assigned a score according
to the intensity of the nucleic, cytoplasmic, and/or mem-
brane staining (no staining, not detected = 0; weak stain-
ing, light yellow = 1; moderate staining, yellowish brown =
2; strong staining, brown =3) and the extent of stained
cells (no staining = 0, 1-24% = 1, 25-49% = 2, 50-74% = 3,
75-100% = 4). The final immunoreactive score was deter-
mined by multiplying the intensity score with the extent
score of stained cells, ranging from 0 (the minimum) to
12 (the maximum).
Western blotting
Cells were solubilized in the extraction buffer (0.5%
Lubrol-PX, 50 mM KCl, 2 mM CaCl2, 20% glycerol,
50 mM Tris–HCl, and inhibitors of proteases and phos-
phatases, pH 7.4) at 4°C for 30 min and centrifuged
(12,000 rpm, 15 min at 4°C) to maintain the supernatant.
Protein concentrations were determined by Bradford
assay (Bio-Rad, CA). Proteins were resolved by SDS-
PAGE and transferred to a polyvinylidene difluoride
membrane (Bio-Rad), and then probed with the specified
primary antibody followed by the appropriate secondary
antibody. The immunostaining was visualized by using
Kodak X-ray films, and quantified by scanning films con-
taining nonsaturated signals with an Epson 1680 scanner
before analyzed with ImageJ software [20].Immunoprecipitation
Supernatant of the cell lysates was incubated with indi-
cated antibodies and protein-G agarose beads at 4°C
overnight. The beads were washed with the buffer (0.1%
Lubrol-PX, 50 mM KCl, 2 mM CaCl2, 20% glycerol,
50 mM Tris–HCl, and inhibitors of proteases and phos-
phatases, pH 7.4), then subjected to SDS-PAGE and sub-
sequent immunoblotting with antibodies.
Cell viability analysis
Cell viability assay was performed using 3-(4,5-dimethyl-
thiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT,
Sigma) reduction assay [21]. Briefly, cells were seeded at
a density of 300 cells per well in a 96-well plate and cul-
tured for indicated days. Culture medium was replaced
with fresh media every day. MTT (20 μl) was added for
4 h to allow formation of the colored formazan product.
Then, the supernatant was replaced with 150 μl dimethyl
sulfoxide (DMSO). Plates were incubated for a further
2 h and then optical density was measured using a mi-
croplate ELISA reader (Bio-Rad) at 490 nm. The relative
survival rates were presented as the percentage of con-
trol. Triplicate wells were used for each cell line. Each
experiment was repeated three times.
Scratching assay
Cell migration was measured using a scratch assay [22].
AGS cells were plated in 6-well plates to create a confluent
monolayer. At a confluence of 90-100%, a 200 μl pipette
tip was used to make a “scratch” in the cell monolayer.
Then the cells were transfected with SPOP plasmid or
empty plasmid as control for 24 h. After removing debris
and adding fresh media containing 2% FBS, cells were
photographed using phase contrast microscopy (Olympus,
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software. A relative migration rate was calculated by cell
relative migration rate for each treatment.Colony formation assay
One or two hundred cells were plated into 6 cm dishes
and incubated in DMEM with 10% FBS at 37°C. Two
weeks later, the cells were fixed and stained with 0.1%
crystal violet. The number of colonies, defined as >50
cells/colony, were counted. The experiments were per-
formed in triplicate.Real-time PCR
Total RNA (1 μg) was employed to prepare cDNA via
reverse transcription using cDNA synthesis kit (Invitro-
gen) according to manufacturer’s instructions and ana-
lyzed using an Applied Biosystems 7500 PCR Detection
System (Applied Biosystems Inc.). Target gene mRNA ex-
pressions were normalized to the expression of GAPDH
and quantified using the comparative Ct method. The
primers used for real-time PCR are as follows: SPOP
(forward, 5′-CAA GGC AAA GAC TGG G-3′; Reverse,
5′-AAC ACT CAC CTC GCA GA-3′); Gli1 (forward, 5′-
TCC TAC CAG AGT CCC AAG TT-3′; reverse, 5′- CCC
TAT GTG AAG CCC TAT TT-3′); Gli2 (forward, 5′-
CCT GGC ATG ACT ACC ACT ATG AG-3′; reverse,
5′-GGC TTG GCT GGC ATG TTG-3′); β-actin (for-
ward, 5′-CGG GAA ATC GTG CGT GAC-3′; reverse,
5′-ATG CCC AGG AAG GAA GGC T-3′).Dual luciferase reporter assay
We inserted Gli binding sites (8 × GBS) into plasmid
PGL4.2 in HEK293T cells and screened for stable cell
lines [23]. Myc-SPOP or empty vector were co-transfected
into the cells for 48 h. Luciferase activity was assayed
using dual luciferase reporter assay system with procedure
described by the manufacturer (Promega, Madison, WI).
Change of luciferase activity in treated cells was expressed
as percentage of the controls.Immunofluorescence analysis
MKN45 cells were transfected with Myc-SPOP, miR-SPOP
or empty vector as control. Approximately 48 h after trans-
fection, cells were fixed with 4% paraformaldehyde/
phosphate-buffered saline (PBS), permeated with 0.1%
Triton/PBS, blocked in 3% BSA/PBS for 30 min, and
then incubated with indicated antibodies (1: 200) in
2% BSA/PBS at 4°C overnight. Double-labelled immu-
nostaining was done with appropriate fluorochrome-
conjugated secondary antibodies. Protein localization
was visualized using a Zeiss-700 (Jena, Germany) con-
focal microscope.Statistical analysis
Values were indicated as mean ± SD. The differences be-
tween the groups were evaluated by Student’s t test or
one-way analysis of variance (ANOVA). For the relation-
ship between SPOP expression and clinical pathologic
factors, the Chi-square (χ2) test, Fisher’s exact test and
Spearman’s correlation were used. All analyses were carried
out by the use of SPSS17.0 software (SPSS Inc., Chicago,
IL). Differences were considered significant if P < 0.05.
Results
Clinical significance of SPOP expression in gastric cancer
Eighty eight gastric cancer cases were eligible for our
study. SPOP protein expression was found in most GC
tissues and adjacent gastric tissues. Interestingly, the im-
munostaining of SPOP was much less in GC tissues than
in paired adjacent tissues (Figure 1A). In high power
field, SPOP was mainly expressed in the cytoplasm and
nuclear of adjacent gastric mucosa epithelium cells but
less or no staining in gastric cancer cells. The immuno-
histochemical scoring of SPOP revealed a significant dif-
ferential staining between GC group and adjacent gastric
tissue group (P < 0.05), indicating a critical role of SPOP
in tumorigenesis of GC (Figure 1B,C). Then, we ran-
domly selected 4 pairs of tissues to detect SPOP protein
expression using Western blotting. Consistent with the
results above, SPOP protein was found less in GC than
in adjacent gastric tissues in most cases (Figure 1D).
We further analyzed the correlation between SPOP ex-
pression and clinical pathologic characteristics of patients.
Since SPOP scoring ranged from 0 to 12, we defined the
score less than 6 as low expression, and equal or more
than 6 as high expression. As shown in Table 1, it is not-
able that SPOP was negatively correlated with lymph node
metastasis, poor histopathologic differentiation and ad-
vanced TNM stages, regardless of age and gender. Taken
together, these results indicate that SPOP is a potential
oncogenic suppressor.
SPOP inhibits gastric cancer cell proliferation and
migration
SPOP protein is detected in several human GC cell lines
(MKN45, MKN28, AGS, SGC7901) and human gastric
mucosal cell line GES-1 by Western blotting assay
(Figure 2A). The expression of SPOP protein in differ-
ent gastric cell lines is imbalanced. We found much higher
SPOP expression in MKN28 and MKN45 cells when com-
pared with a relatively low expression in GES-1, AGS and
SGC-7901 cells. In order to study effects of SPOP on GC,
we generated SPOP transfected AGS cells and two stable
cell lines (marked as #1, #2) were screened for further
studies (Figure 2B). In MTT cell viability assays, as shown
by Figure 2C, cell proliferated in all groups in course of
time. As expected, SPOP slowed down proliferation of
Figure 1 SPOP expression in gastric cancer. (A) The representative photos of SPOP expression in gastric cancer tissues and adjacent gastric
tissues by using immunohistochemical staining (DAB staining, scale bar, 40 μm). Magnified local images reflecting detailed information were
shown on the bottom. (B, C) SPOP expression was plotted using the immunochemical scores as described in the Methods. B, plot of SPOP
scores in each gastric carcinoma and adjacent tissues. C, scores of SPOP expression are shown as box plots. The horizontal lines represent the
median. The bottom and top edges of the boxes represent the 25th and 75th percentiles, respectively. And the vertical bars represent the range
of the data. n = 88. (D) Representative immunoblotting of SPOP protein in gastric cancer samples. C refers to gastric cancer tissue and A refers to
paired adjacent non-tumor gastric tissue from the same patient.
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transfected AGS cells (Control). In addition, AGS cell
migration was attenuated by over-expressed SPOP in
wound healing assay (Figure 2D,E). Colony formation
assay revealed that the SPOP transfected AGS cells
formed significantly less colonies than control AGS cells
(Figure 2F,G). These in vitro results further confirmed that
SPOP is a potential tumor suppressor in GC.
Repression of SPOP promotes proliferation and migration
of MKN45 cells
We next selected MKN45 cells to study the effects of
down-regulation of SPOP on cancer cell proliferation
and migration. We screened a stable cell line expressing
GFP-tagged miR-SPOP in MKN45 cells by flow cytometry
after 48 h incubation, and a diminished expression of SPOP
protein was detected by Western blotting (Figure 3A). The
cell viability of all GFP-tagged cells was suddenly in-
creased from the 5th day of incubation, and the cells with
repressed SPOP showed stronger viability than the control(Figure 3B). In order to examine the rate of cell prolifera-
tion, we performed immunofluorescent staining of Ki-67
in miR-SPOP transfected MKN45 cells. We observed in-
creased fluorescence intense of Ki-67 in the nucleus of
miR-SPOP transfected cells (Figure 3C, indicated with
arrow heads). Moreover, repression of SPOP effect-
ively enhanced AGS cell migration and colony formation
(Figure 3D-G). Therefore, these results indicate that down-
regulation of SPOP expression promotes proliferation and
migration of human GC cells.
SPOP inhibits Hh/Gli2 signaling activity
To explore the molecular basis that SPOP suppresses
tumorigenesis, we studied the relationship of SPOP and
Hh signaling pathway which is generally accepted to be
involved in tumorigenesis [4,24,25]. Immunoprecipitation
showed the interaction of Gli2 with SPOP in MKN28 cells
(Figure 4A). With increasing expression of SPOP, mRNA
of Gli1 and Gli2 detected by real-time PCR had no signifi-
cant change (Figure 4B). However, the immunoreactive
Figure 2 SPOP inhibits gastric cancer cell proliferation and migration. (A) The expression of SPOP protein in human GC cell lines - MKN45,
MKN28, AGS, SGC7901, and human gastric mucosal cell line GES-1 by Western blotting. (B) Detection of SPOP expression in transfected AGS cells.
Expression of SPOP was detected in cell lysates of SPOP-V5 transfected AGS cells by Western blotting. Control, AGS cells with empty vector plasmid;
#1 and #2 represent different groups of stable AGS cell lines transfected with SPOP. (C) Decreased viability of gastric cancer cells transfected with SPOP.
The viability of AGS cells was assessed by using an MTT assay. Data represent the average of three experiments (mean ± SD). **P < 0.01, compared to
control cells. (D, E) Reduced migration of AGS cells following treatment with SPOP transfection. Cell migration was examined using a scratch assay.
D, images acquired at indicated time points. E, quantification of cell migration rates. Data represent the average of three experiments (mean ± SD).
**P< 0.01, compared to DMSO treated cells. (F, G) Colony formation of SPOP over-expressed AGS cells. One or two hundred stable cell lines with SPOP
over-expression were seeded into 12-well plates for 2 weeks. Colonies were fixed and stained with crystal violet, then counted if the colonies > 50 cells. G,
histograms show the rate of colony formation. Data represent the average of three experiments (mean ± SD). **P< 0.01, compared to DMSO treated cells.
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along with the increasing SPOP (Figure 4C). These results
indicate a role that SPOP affects Gli2 on post-transcriptional
degradation but not on its transcription. A proteasome
inhibitor MG-132 was used to inhibit proteasome-
dependent degradation of Gli2 protein (Figure 4D).
Gli2 degradation was attenuated by treatment with MG-
132. However, Gli2 abundance under the treatment of MG-
132 can be reduced when SPOP was repressed in trans-
fected cells. These data suggested that SPOP regulates the
stability of Gli2 through proteasome-dependent pathway.
In addition, dual luciferase reporter assay was performedand we found that increasing Myc-SPOP led to a dose-
dependent decrease of Gli transcription activity in
HEK293T cells (Figure 4E). We then generated Myc-SPOP
transfected MKN45 cells to detect SPOP and endogenous
Gli2 expression. We found that the intensity of Gli2 stain-
ing was negatively related to SPOP intensity in cytoplasm
and perinuclear region (Figure 4F).
SPOP promotes apoptosis of gastric cancer cells
Several studies indicate that SPOP regulates apoptosis in
tumor cells [12,26]. However, apoptotic function of
SPOP in gastric cancer was seldom studied. Therefore,
Figure 3 Repression of SPOP promotes proliferation and migration of gastric cancer cells. (A) MKN45 cells were transfected with GFP-tagged
miR-SPOP and screened by flow cytometry for the stable cells. Western blotting was performed to detect SPOP expression. (B) Repression of SPOP
enhances gastric cancer cell viability. The viability of MKN45 cells was assessed using an MTT assay. Data represent the average of three experiments
(mean ± SD). *P < 0.05, compared to control cells. (C) Repression of SPOP promotes Ki-67 expression in nucleus. Immunofluorescent stainings of
transfected miR-SPOP and endogenous Ki-67 were performed in MKN45 cells. MKN45 cells were transfected with GFP-tagged miR-SPOP for 48 h.
Ki-67 was detected by incubating cells with mouse anti-Ki-67 and subsequently with Alexa Fluor 594 goat anti-mouse antibodies. Nucleus was
identified by DAPI staining. (D, E) Repression of SPOP accelerates MKN45 cell migration in a scratch assay. Bars represent the standard deviation
of three independent experiments. **P < 0.01, compared to DMSO treated control. (F) Repression of SPOP increases gastric cancer cell colony
formation. Two hundred stable miR-SPOP transfected MKN45 cells were seeded into 12-well plates for 2 weeks. Colonies were fixed and stained
with crystal violet and then counted if the colonies > 50 cells. (G) Histograms show the colony formation rate. Data represent the average of three
experiments (mean ± SD). **P < 0.01, compared to DMSO treated cells.
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serve effects of over-expressed or repressed SPOP on
apoptosis. As shown in Figure 5A, in Myc-SPOP trans-
fected cells, Hh/Gli pathway related apoptotic proteins,
such as Caspase-3, cleaved Caspase-3 and PARP are all
increased. Nevertheless, repressed SPOP resulted in de-
creased Caspase-3, cleaved Caspase-3, tumor suppressor
PTEN, and Cyclin-dependent kinase inhibitors p16, p21
and p27 (Figure 5B). In addition, Cyclin B1 whichpromotes several events of early mitosis, PCNA (prolif-
erating cell nuclear antigen), p-ERK and Daxx are upreg-
ulated when SPOP was knockdown. No tendency of
DUSP7 abundance was observed (Figure 5B). Since the
active form of Caspase-3 (cleaved Caspase-3) marks the
frequency of cell apoptosis, we examined the expression
of cleaved Caspase-3 in SPOP over-expressed gastric
cancer cells and gastric cancer tissues by immunofluor-
escent and immunohistochemical staining methods.
Figure 4 SPOP inhibits Hh/Gli signaling activity. (A) SPOP interacts with Gli2 protein in MKN28 cells by co-immunoprecipitation method. Goat
anti-rabbit IgG is used as negative control. (B) Quantification of Gli1 and Gli2 mRNA in Myc-SPOP transfected MKN28 cells. (C) Increasing SPOP
reduced Gli2 expression. AGS cells were transfected with different amount of Myc-SPOP for 48 h. Full length of Gli2 is detected in cell lysates
by Western blotting. (D) SPOP promotes Gli2 degradation through proteasome pathway. MKN45 cells were treated with vehicle (DMSO) or
miR-SPOP for 48 h, with or without 10 mM MG-132. In order to limit toxicity, MG-132 was added 4 h before cell harvest. Lysates were subjected
to immunoblotting with indicated antibodies. (E) Dual luciferase reporter assay is performed in HEK293T cells. Myc-SPOP were transfected into
the cells and lysed after 48 h incubation. The percentage of decrease in luciferase activity was calculated. (F) SPOP affects Gli2 abundance in
cytoplasm. Immunofluorescent stainings of transfected Myc-SPOP and endogenous Gli2 were performed in MKN45 cells. MKN45 cells were
transfected with Myc-SPOP for 48 h. Myc-SPOP was detected by incubating cells with mouse anti-Myc antibody and subsequently Alexa Fluor
594 goat anti-mouse antibody. Gli2 was detected by incubating cells with rabbit anti-Gli2 antibody and subsequently Alexa Fluor 488 donkey
anti-rabbit antibody. Nucleus was identified by DAPI staining.
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Myc-SPOP transfected AGS cells (Figure 5C). In human
gastric cancer tissues, immunostaining of cleaved Caspase-
3 was mainly found in adjacent gastric tissues but much
less in cancer tissues (Figure 5D). Taken together, these re-
sults indicate that SPOP plays critical roles in gastric can-
cer cell apoptosis.
A working model is shown in Figure 6. In brief, Gli2 is
normally kept in the cytoplasm. We propose that SPOP
may directly combine with Gli2 and the complex is rec-
ognized by ubiquitin. Then the ubiquitinated Gli2 en-
counters a proteasome-dependent degradation. Or SPOP
acts to inhibit Gli2-mediated transcriptional activation
and thereby block the effect of Gli2 on the activation of
target genes, thus further impact on initiation of cancer
cell proliferation, migration, invasion and apoptosis.Discussion
SPOP is an E3 ubiquitin ligase adaptor and its role in
tumorigenesis is largely unknown. In this study, we de-
scribed the relationship between SPOP expression and
clinical pathology parameters of 88 GC cases by immuno-
histochemical analysis. Interestingly, immunostaining of
SPOP is differentially detected in GC tissues and adjacent
gastric tissues. Dramatically decreased SPOP expression in
GC tissues indicates a role of it in gastric cancer process-
ing. Further correlation analysis revealed that SPOP ex-
pression was negatively related to lymph node metastasis,
poor histopathologic differentiation and advanced TNM
stages. In vitro experiments provide evidence that SPOP
functions as a tumor suppressor in different gastric cancer
cell lines and contributes to post-transcriptional modifica-
tion of Gli2. Intracellular studies found that SPOP
Figure 5 SPOP promotes tumor cell apoptosis. (A) Overexpression of SPOP upregulates the expression of apoptotic proteins. MKN45 cells
were transfected with Myc-SPOP and incubated for 48 h. Target proteins in cell lysates were detected by indicated antibodies using Western
blotting. (B) Repression of SPOP inhibits cancer cell apoptosis. MKN45 cells were transfected with miR-SPOP-1430 and incubated for 48 h. Target
proteins in cell lysates were probed with indicated antibodies using Western blotting. (C) Overexpressed SPOP promotes cleaved Caspase-3
expression. AGS cells were transfected with Myc-SPOP for 48 h and then fixed. Myc-SPOP was detected by incubating cells with mouse anti-Myc
antibody and subsequently Alexa Fluor 488 goat anti-mouse antibody. Cleaved Caspase-3 was detected by incubating cells with rabbit anti-cleaved
Caspase-3 and subsequently Alexa Fluor 594 donkey anti-rabbit antibody. Nucleus was identified by DAPI staining. (D) The representative photos of
cleaved Caspase-3 expression in gastric cancer tissues and adjacent gastric tissues by using immunohistochemical staining (DAB staining, scale bar,
100 μm). Magnified local images reflecting detailed information were shown on the bottom.
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SPOP promotes tumor cell apoptosis through regulating
the expression of Hh/Gli related apoptotic proteins. To-
gether, our study elucidates the tumor protective function
of SPOP through inhibiting Hh/Gli2 pathway, and the pos-
sible molecular mechanism of Gli2 stability regulated by
SPOP.
Aberrant activation of Hh pathway has been reported
in the proliferation of a variety of human cancers, such
as BCCs, gastric cancers, prostate cancers, breast can-
cers, pancreatic cancers [27-34]. As the end effectors of
canonical Hh signaling pathway, Gli family play roles of
transcription factors, and the abnormal regulation of Gli
proteins leads to tumorigenesis [35,36]. Their activity is
tightly regulated through various posttranslational modi-
fications, such as ubiquitin-mediated degradation, pro-
teolytic processing, and nuclear-cytoplasmic shuttling. Inthe present study, Gli mRNA and protein were differen-
tially affected by SPOP in human gastric epidermal cell
lines, suggesting a post-transcription modification of
Gli by SPOP. As an E3 ubiquitin ligase adaptor, SPOP
is supposed to process in degradation of Gli depending
on ubiquitin/proteasome system. In fact, a recent study
confirmed our speculation [17]. Wang C., et al. found that
treatment with proteasome inhibitor MG-132 inhibited
SPOP-mediated full-length Gli2 and Gli3 degradation.
Co-expression of SPOP and Myc-tagged ubiquitin with
either Gli2 or Gli3 resulted in increased levels of ubi-
quitinated forms of both Gli2 and Gli3 proteins, although
the extent of ubiquitination between the two proteins was
different. In our study, we demonstrated that increasing
exogenous SPOP expression led to decreased endogenous
Gli2 both in cytoplasm and nucleus, which provided
another direct evidence of Gli2 turnover by SPOP. The
Figure 6 A working model. Gli2 is normally kept in the cytoplasm. We propose that SPOP may directly combine with Gli2 and the complex is
recognized by ubiquitin. Then the ubiquitinated Gli2 encounters a proteasome-dependent degradation. Or SPOP acts to inhibit Gli2-mediated
transcriptional activation and thereby block the effect of Gli2 on the activation of target genes, thus further impact on initiation of cancer cell
proliferation, migration, invasion, and apoptosis.
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http://www.jeccr.com/content/33/1/75biological function of Gli2 is suggested to translocate to the
nucleus, where it acts as a transcriptional activator [37]. Ac-
tually, we did find endogenous Gli2 expression within the
nucleus by immunofluorescent staining, and diminished
markedly when SPOP overexpressed. In other words,
SPOP interferes Gli2 nucleus/cytoplasm shuttling thus
further blocks Gli2 function as a transcription activator in
tumorigenesis.
Our proposed degradation of Gli2 by SPOP is analo-
gous to that of Ci by the HIB/Cul3 complex in Drosoph-
ila [38]. Like HIB, exogenous mammalian SPOP may
recruit Cul3 from the cytoplasm along with degradation
substrates, likely including Gli2. The molecular basis of
Gli2 degradation by SPOP is affected by another inhibi-
tory regulator for Gli proteins-SuFu, which is localized
to both the cytoplasm and the nucleus. SuFu sequesters
Gli proteins in the cytoplasms, and in the nucleus SuFu
plays as a co-repressor of Gli proteins [39]. SuFu and
SPOP competitively interact with Gli2 and Gli3 proteins,
and SPOP is likely to exhibit a lower binding affinity
than SuFu to Gli2 and Gli3 [17]. This might ensure the
prompt activation and deactivation of Gli2 and Gli3 pro-
teins in response to Hh signaling.
Limited studies suggest that SPOP also behaves in
apoptosis. A study revealed that SPOP BTB protein
serves as an adaptor of Daxx, which is a pro-apoptotic
protein under various stress condition [12]. Likewise,
our data proved that SPOP knockdown by miR-SPOP
transfection resulted in reduced expression of Caspase-3,
cleaved Caspase-3, p16, p27, and p21 which are cell
cycle inhibitors. Furthermore, we found that repressed
SPOP promotes early mitosis through enhancing the ex-
pression of PCNA and Cyclin B1 respectively. Thesemay indicate a function of SPOP besides E3 ligase
adaptor.
Noted that in the control groups of our cultured
AGS cell line and MKN45 cell line (Figure 2D,F and
Figure 3C,E), under the same incubatory condition,
the baseline cell ability of migration and proliferation
were different from each other. Lower expression of
SPOP may contribute to a more severe malignancy of
AGS cells than MKN45 cells.
A recent published study of clear cell renal cell cancer
(ccRCC) raises another question that SPOP acts as mul-
tiple regulators of cellular proliferation and apoptosis, in-
cluding not only Gli2 but also tumor suppressor - PTEN,
ERK phosphatases and pro-apoptotic molecule Daxx [39].
Thus the total effect of SPOP on clear cell renal cell car-
cinoma is promoting tumorigenesis. However, in our gas-
tric cancer cell line MKN45, different from ccRCC study,
tumor suppressor PTEN was reduced and p-ERK was acti-
vated when SPOP was repressed (Figure 5B). These dis-
crepancies indicate multiple roles of SPOP in tumors from
different sources of tissues, and the molecular mecha-
nisms are under investigation.
Conclusions
We report herein that SPOP negatively regulates Hh/
Gli2 signaling pathway mediated transcription through
interfering Gli2 abundance in gastric cell lines, thus
results in decreased tumor cell proliferation, invasion,
migration and enhanced cell apoptosis. The identifi-
cation of SPOP as a negative regulator of Gli2-mediated
transcription may provide an alternative strategy for
developing therapeutic agents for gastric cancer in
future.
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